Trademark: 97030469
Word
SYNER-G BIOPHARMA GROUP
Status Date
Tuesday, May 28, 2024
Registration Number
7402522
Registration Date
Tuesday, May 28, 2024
Filing Date
Thursday, September 16, 2021
Published for Opposition
Tuesday, August 8, 2023
35 Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
45 Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences
42 Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials
The mark consists of a stylized pyramid with one side consisting of a solid triangle and the other side consisting of lines forming a triangle appearing to the left of the stylized word "SYNER-G" above the stylized words "BioPharma Group" with the words separated by a horizontal line.
SYNERGY BIOPHARMACEUTICAL GROUP
"BIOPHARMA GROUP"
Sep 20, 2021
New Application Entered
Oct 21, 2021
New Application Office Supplied Data Entered
Oct 22, 2021
Notice Of Design Search Code E-Mailed
Jun 8, 2022
Automatic Update Of Assignment Of Ownership
Jun 21, 2022
Assigned To Examiner
Jun 21, 2022
Non-Final Action Written
Jun 21, 2022
Non-Final Action E-Mailed
Jun 21, 2022
Notification Of Non-Final Action E-Mailed
Dec 5, 2022
Teas Response To Office Action Received
Dec 5, 2022
Correspondence Received In Law Office
Dec 6, 2022
Teas/Email Correspondence Entered
Jan 3, 2023
Suspension Letter Written
Jan 3, 2023
Letter Of Suspension E-Mailed
Jan 3, 2023
Notification Of Letter Of Suspension E-Mailed
Jul 5, 2023
Approved For Pub - Principal Register
Jul 19, 2023
Notification Of Notice Of Publication E-Mailed
Aug 8, 2023
Published For Opposition
Aug 8, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 26, 2023
Teas Change Of Owner Address Received
Oct 26, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 26, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 26, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 26, 2023
Teas Change Of Correspondence Received
Apr 2, 2024
Teas Statement Of Use Received
Apr 2, 2024
Use Amendment Filed
Apr 20, 2024
Case Assigned To Intent To Use Paralegal
Apr 20, 2024
Statement Of Use Processing Complete
Apr 24, 2024
Allowed Principal Register - Sou Accepted
May 28, 2024
Registered-Principal Register
May 28, 2024
Notice Of Registration Confirmation Emailed
Apr 24, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
